BJDX
NASDAQ · Health Care
Bluejay Diagnostics Inc
$3.39
+0.41 (+13.76%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.48M | 1.49M | 1.30M |
| Net Income | 82.9K | 99.7K | 70.4K |
| EPS | — | — | — |
| Profit Margin | 5.6% | 6.7% | 5.4% |
| Rev Growth | +21.6% | -6.7% | +20.3% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 1.07M | 981.3K | 871.2K |
| Total Equity | 1.06M | 1.10M | 1.01M |
| D/E Ratio | 1.01 | 0.89 | 0.86 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 120.1K | 112.7K | 103.3K |
| Free Cash Flow | 69.0K | 73.7K | 63.9K |